Soligenix, Inc.
SNGX • NASDAQ
Soligenix, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher J. Schaber, with a market cap of $11.7M.
Market Cap$11.7M
Employees15.0
CEOChristopher J. Schaber
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 8, 2026 · In 3 weeksQ1 2026
Financials
Soligenix, Inc. FAQ
Common questions about Soligenix, Inc.
Soligenix, Inc. is scheduled to report earnings for Q1 2026 on May 8, 2026.
Soligenix, Inc. has approximately 15 employees.